Inhibiting roles of berberine in gut movement of rodents are related to activation of the endogenous opioid system

Phytotherapy Research

Volumn 27, Issue 10, 2013, Pages 1564-1571

  Feng, Yajing ^a   Li, Yongyu ^a   Chen, Chunqiu ^a   Lin, Xuhong ^a   Yang, Yuehua ^a   Cai, Haidong ^a   Lv, Zhongwei ^a   Cao, Minghua ^a   Li, Kun ^a   Xu, Jing ^a   Li, Sainan ^a   Jia, Yijun ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Berberine; endogenous opioid system; gastrointestinal hormones; gastrointestinal motility

Indexed keywords

BERBERINE; BETA ENDORPHIN; DYNORPHIN A; GASTRIN; GLUCAGON LIKE PEPTIDE 1; METENKEPHALIN; MOTILIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ARTICLE; COLON MOTILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTRIN BLOOD LEVEL; GASTROINTESTINAL TRANSIT; HORMONAL REGULATION; INTESTINE MOTILITY; JEJUNUM MOTILITY; MALE; MOUSE; MYOELECTRICITY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RAT; SOMATOSTATIN BLOOD LEVEL; UPPER GASTROINTESTINAL TRACT; UPREGULATION;

MUS; RATTUS; RODENTIA;

BERBERINE; ENDOGENOUS OPIOID SYSTEM; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MOTILITY;

ANIMALS; BERBERINE; BETA-ENDORPHIN; COLON; DYNORPHINS; ENKEPHALIN, METHIONINE; GASTRINS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; GLUCAGON-LIKE PEPTIDE 1; JEJUNUM; MALE; MICE; MICE, INBRED BALB C; MOTILIN; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 84885632071     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4926     Document Type: Article

References (27)

1. Bhutada P, Mundhada Y, Bansod K, et al,. 2011. Berberine protects C57BL/6J mice against ethanol withdrawal-induced hyperexcitability. Phytother Res 25: 302-7.
2. Camilleri M, Vazquez-Roque M, Iturrino J, et al,. 2012. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol 303: G120-8.
3. Capasso R, Borrelli F, Cascio MG, et al,. 2008. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. Br J Pharmacol 155: 681-9.
4. Ciobanu L, Dumitrascu DL,. 2011. Gastrointestinal motility disorders in endocrine diseases. Polskie Archiwum Medycyny Wewnetrznej 121: 129-36.
5. Cosola C, Albrizio M, Guaricci AC, et al,. 2006. Opioid agonist/antagonist effect of naloxone in modulating rabbit jejunum contractility in vitro. J Physiol Pharmacol 57: 439-49. (Pubitemid 44543878)
6. Eaker EY, Sninsky CA,. 1989. Effect of berberine on myoelectric activity and transit of the small intestine in rats. Gastroenterology 96: 1506-13. (Pubitemid 19138693)
7. Fourmy D, Gigoux V, Reubi JC,. 2011. Gastrin in gastrointestinal diseases. Gastroenterology 141: 814-8-e1-3.
8. Gray AC, White PJ, Coupar IM,. 2005. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum. Br J Pharmacol 144: 687-94. (Pubitemid 40445617)
9. Greenwood VM, Gardner CJ, Little PJ, Hicks GA, Dehaven-Hudkins DL,. 2004. Preclinical studies of opioids and opioid antagonists on gastrointestinal function. Neurogastroenterol Motil 16 (Suppl 2): 46-53. (Pubitemid 39468866)
10. Gulfraz M, Mehmood S, Ahmad A, Fatima N, Praveen Z, Williamson EM,. 2008. Comparison of the antidiabetic activity of Berberis lyceum root extract and berberine in alloxan-induced diabetic rats. Phytother Res 22: 1208-12.
11. Hamsa TP, Kuttan G,. 2012. Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. Phytother Res 26: 568-78.
12. Hu PF, Chen WP, Tang JL, Bao JP, Wu LD,. 2011. Protective effects of berberine in an experimental rat osteoarthritis model. Phytother Res 25: 878-85.
13. Ikarashi N, Tajima M, Suzuki K, et al,. 2012. Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3 T3-L1 cultures. Phytother Res 26: 91-100.
14. Imanshahidi M, Hosseinzadeh H,. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22: 999-1012.
15. Kaneko K, Iwasaki M, Yoshikawa M, Ohinata K,. 2010. Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems. Am J Physiol Gastrointest Liver Physiol 299: G799-805.
16. Kong W, Wei J, Abidi P, et al,. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10: 1344-51. (Pubitemid 40022716)
17. Kulkarni SK, Dhir A,. 2010. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24: 317-24.
18. Li B, Zhu WL, Chen KX,. 2008. [ Advances in the study of berberine and its derivatives ]. Yao xue xue bao=Acta Pharmaceutica Sinica 43: 773-87.
19. Li YY, Sibaev A, Zhou MZ, Zhu GY, Yuce B, Storr M,. 2007. The Chinese herbal preparation Qing Yi Tang (QYT) improves intestinal myoelectrical activity and increases intestinal transit during acute pancreatitis in rodents. Phytother Res 21: 324-31. (Pubitemid 46595975)
20. Lin XH, Yuece B, Li YY, et al,. 2011. A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents. Neurogastroenterol Motil 23: 862-e342.
21. Liu GS, Liu LF, Lin CJ, et al,. 2006. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway. Mol Pharmacol 69: 440-51.
22. Lu B, Zhao J, Xu L, Xu Y, Wang X, Peng J,. 2012. Identification of molecular target proteins in berberine-treated cervix adenocarcinoma HeLa cells by proteomic and bioinformatic analyses. Phytother Res 26: 646-56.
23. Sanders KM, Koh SD, Ward SM,. 2006. Interstitial cells of cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol 68: 307-43.
24. Sternini C, Patierno S, Selmer IS, Kirchgessner A,. 2004. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil 16 (Suppl 2): 3-16. (Pubitemid 39468862)
25. Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI,. 2012. Berberine: New perspectives for old remedies. Biochem Pharmacol DOI: 10.1016/j.bbr.2011.03. 031.
26. Wood JD, Galligan JJ,. 2004. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 16 (Suppl 2): 17-28. (Pubitemid 39468863)
27. Zhu X, Guo X, Mao G, et al,. 2012. Hepatoprotection of Berberine Against Hydrogen Peroxide-induced Apoptosis by Upregulation of Sirtuin 1. Phytother Res DOI: 10.1002/ptr.4728.